Skip to main content
. 2018 Jan 29;15(4):4241–4247. doi: 10.3892/ol.2018.7905

Figure 5.

Figure 5.

Kaplan-Meier analysis of RFS in the HLA-A*2402 matched group. Patients with positive CTL responses had a significantly better RFS than those without (HR=0.159, 95% CI: 0.023–0.697, P=0.011). RFS, relapse-free survival; HLA-A, human leukocyte antigen-A; HR, hazard ratio; CI, confidence interval; CRC, colorectal cancer; CTL, cytotoxic T lymphocyte.